FDA Calls for Stronger Warnings on Sleep Drugs, Includes Sepracor, Inc.(Jobs)'s Lunesta and Sanofi-Aventis (France)'s Ambien

March 14, 2007 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Wednesday ordered sleep disorder drugs to carry stronger warnings about their risks, such as drowsy driving and severe allergic reactions.>>> Discuss This Story

Twitter
LinkedIn
Facebook
Email
Print

Food and Drug Administration (FDA) Sanofi (France)